These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25028601)

  • 1. Effects of high-fat diet and the anti-diabetic drug metformin on circulating GLP-1 and the relative number of intestinal L-cells.
    Kappe C; Zhang Q; Nyström T; Sjöholm A
    Diabetol Metab Syndr; 2014; 6():70. PubMed ID: 25028601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of lipoapoptosis and metformin protection in GLP-1 secreting cells.
    Kappe C; Holst JJ; Zhang Q; Sjöholm A
    Biochem Biophys Res Commun; 2012 Oct; 427(1):91-5. PubMed ID: 22982676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin sensitizers improve the GLP-1 secretion and the amount of intestinal L cells on high-fat-diet-induced catch-up growth.
    Zheng J; Xiao KL; Chen L; Wu C; Hu X; Zeng T; Chen XQ; Li WJ; Deng X; Li H; Li YM
    Nutrition; 2017; 39-40():82-91. PubMed ID: 28606576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin reduces body weight gain and improves glucose intolerance in high-fat diet-fed C57BL/6J mice.
    Matsui Y; Hirasawa Y; Sugiura T; Toyoshi T; Kyuki K; Ito M
    Biol Pharm Bull; 2010; 33(6):963-70. PubMed ID: 20522960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A refined-JinQi-JiangTang tablet ameliorates prediabetes by reducing insulin resistance and improving beta cell function in mice.
    Gao LH; Liu Q; Liu SN; Chen ZY; Li CN; Lei L; Sun SJ; Li LY; Liu JL; Shen ZF
    J Ethnopharmacol; 2014; 151(1):675-85. PubMed ID: 24286962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLP-2 as Beneficial Factor in the Glucose Homeostasis in Mice Fed a High Fat Diet.
    Baldassano S; Rappa F; Amato A; Cappello F; Mulè F
    J Cell Physiol; 2015 Dec; 230(12):3029-36. PubMed ID: 25967277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus.
    Cuthbertson J; Patterson S; O'Harte FP; Bell PM
    Metabolism; 2011 Jan; 60(1):52-6. PubMed ID: 20152998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin protects against lipoapoptosis and enhances GLP-1 secretion from GLP-1-producing cells.
    Kappe C; Patrone C; Holst JJ; Zhang Q; Sjöholm A
    J Gastroenterol; 2013 Mar; 48(3):322-32. PubMed ID: 22850868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide 1 receptor agonist ameliorates the insulin resistance function of islet β cells via the activation of PDX-1/JAK signaling transduction in C57/BL6 mice with high-fat diet-induced diabetes.
    Hao T; Zhang H; Li S; Tian H
    Int J Mol Med; 2017 Apr; 39(4):1029-1036. PubMed ID: 28290604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice.
    Maida A; Lamont BJ; Cao X; Drucker DJ
    Diabetologia; 2011 Feb; 54(2):339-49. PubMed ID: 20972533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of proximal and distal small intestinal administration of metformin on plasma glucose and glucagon-like peptide-1, and gastric emptying after oral glucose, in type 2 diabetes.
    Borg MJ; Bound M; Grivell J; Sun Z; Jones KL; Horowitz M; Rayner CK; Wu T
    Diabetes Obes Metab; 2019 Mar; 21(3):640-647. PubMed ID: 30370686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of GLP-1 secretion with anti-hyperlipidemic effect of ginsenosides in high-fat diet fed rats.
    Liu C; Hu MY; Zhang M; Li F; Li J; Zhang J; Li Y; Guo HF; Xu P; Liu L; Liu XD
    Metabolism; 2014 Oct; 63(10):1342-51. PubMed ID: 25060691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal mTOR regulates GLP-1 production in mouse L cells.
    Xu G; Li Z; Ding L; Tang H; Guo S; Liang H; Wang H; Zhang W
    Diabetologia; 2015 Aug; 58(8):1887-97. PubMed ID: 26037201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-rich diet enhances L-cell density in obese subjects and in mice through improved L-cell differentiation.
    Aranias T; Grosfeld A; Poitou C; Omar AA; Le Gall M; Miquel S; Garbin K; Ribeiro A; Bouillot JL; Bado A; Brot-Laroche E; Clément K; Leturque A; Guilmeau S; Serradas P
    J Nutr Sci; 2015; 4():e22. PubMed ID: 26157580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eight weeks of treatment with long-acting GLP-1 analog taspoglutide improves postprandial insulin secretion and sensitivity in metformin-treated patients with type 2 diabetes.
    Gastaldelli A; Nauck MA; Balena R
    Metabolism; 2013 Sep; 62(9):1330-9. PubMed ID: 23831441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sitagliptin and metformin treatment on incretin hormone and insulin secretory responses to oral and "isoglycemic" intravenous glucose.
    Vardarli I; Arndt E; Deacon CF; Holst JJ; Nauck MA
    Diabetes; 2014 Feb; 63(2):663-74. PubMed ID: 24186866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon receptor antagonist upregulates circulating GLP-1 level by promoting intestinal L-cell proliferation and GLP-1 production in type 2 diabetes.
    Lang S; Yang J; Yang K; Gu L; Cui X; Wei T; Liu J; Le Y; Wang H; Wei R; Hong T
    BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32139602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut hormone pharmacology of a novel GPR119 agonist (GSK1292263), metformin, and sitagliptin in type 2 diabetes mellitus: results from two randomized studies.
    Nunez DJ; Bush MA; Collins DA; McMullen SL; Gillmor D; Apseloff G; Atiee G; Corsino L; Morrow L; Feldman PL
    PLoS One; 2014; 9(4):e92494. PubMed ID: 24699248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term low carbohydrate/high-fat diet intake increases postprandial plasma glucose and glucagon-like peptide-1 levels during an oral glucose tolerance test in healthy men.
    Numao S; Kawano H; Endo N; Yamada Y; Konishi M; Takahashi M; Sakamoto S
    Eur J Clin Nutr; 2012 Aug; 66(8):926-31. PubMed ID: 22669333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The entero-insular axis: implications for human metabolism.
    Ranganath LR
    Clin Chem Lab Med; 2008; 46(1):43-56. PubMed ID: 18020966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.